Back
Direxion Daily Cld Cmptng Bl 2X Shs ETF Vs. Avidity Biosciences Industry Stock Comparison
Buy
92
CLDL
Direxion Daily Cld Cmptng Bl 2X Shs ETF
Last Price:
13.60
Seasonality Move:
10.72%
Sell
39
RNA
Avidity Biosciences
Last Price:
46.69
Seasonality Move:
33.04%
Buy
92
Direxion Daily Cld Cmptng Bl 2X Shs ETF (CLDL)
is a Buy
Is Direxion Daily Cld Cmptng Bl 2X Shs ETF a Buy, Sell or Hold?
- The current Direxion Daily Cld Cmptng Bl 2X Shs ETF [CLDL] share price is $13.71. The Score for CLDL is 92, which is 84% above its historic median score of 50, and infers lower risk than normal.
- CLDL is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
39
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $46.71. The Score for RNA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLDL Stock Price Chart
What is Direxion Daily Cld Cmptng Bl 2X Shs ETF's stock price today?
-
The Direxion Daily Cld Cmptng Bl 2X Shs ETF share price today is $13.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDL is experiencing slight buying pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $46.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLDL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 80.82 | Buy |
| Chaikin Money Flow: | 3008 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.72 - 12.32) | Buy |
| Bollinger Bands (100): | (8.83 - 11.03) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 54.01 | Buy |
| Chaikin Money Flow: | 478392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.93 - 47.73) | Buy |
| Bollinger Bands (100): | (41.07 - 46.53) | Buy |
CLDL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.3 | Buy |
| 20-day SMA: | 11.71 | Buy |
| 50-day SMA: | 10.63 | Buy |
| 200-day SMA: | 10.22 | Buy |
| 8-day EMA: | 12.59 | Buy |
| 20-day EMA: | 11.83 | Buy |
| 50-day EMA: | 10.94 | Buy |
| 200-day EMA: | 10.04 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.84 | Buy |
| 20-day SMA: | 45.91 | Buy |
| 50-day SMA: | 44.53 | Buy |
| 200-day SMA: | 33.31 | Buy |
| 8-day EMA: | 45.81 | Buy |
| 20-day EMA: | 45.52 | Buy |
| 50-day EMA: | 44.7 | Buy |
| 200-day EMA: | 34.96 | Buy |
Direxion Daily Cld Cmptng Bl 2X Shs ETF Earnings Growth & CLDL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.40 per share.
Direxion Daily Cld Cmptng Bl 2X Shs ETF Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||